Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation

Mason, 1987, Amiodarone, N Engl J Med, 316, 455, 10.1056/NEJM198702193160807 Kay, 1987, Comparison of survival of amiodarone-treated patients with coronary artery disease and malignant ventricular arrhythmias with that of a control group with coronary artery disease, J Am Coll Cardiol, 9, 877, 10.1016/S0735-1097(87)80245-0 Rosenbaum, 1976, Clinical efficacy of amiodarone as an antiarrhythmic agent, Am J Cardiol, 38, 934, 10.1016/0002-9149(76)90807-9 Heger, 1981, Amiodarone. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation, N Engl J Med, 305, 539, 10.1056/NEJM198109033051002 Waxman, 1982, Amiodarone for control of sustained ventricular tachyarrhythmia: clinical and electrophysiologic effects in 51 patients, Am J Cardiol, 50, 1066, 10.1016/0002-9149(82)90419-2 Fogoros, 1983, Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias, Circulation, 68, 88, 10.1161/01.CIR.68.1.88 Greene, 1983, Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias, J Am Coll Cardiol, 2, 1114, 10.1016/S0735-1097(83)80338-6 Morady, 1983, Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation, Am J Cardiol, 52, 975, 10.1016/0002-9149(83)90515-5 Haffajee, 1983, Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias, Circulation, 67, 1347, 10.1161/01.CIR.67.6.1347 Winkle, 1985, Amiodarone and the American way (editorial), J Am Coll Cardiol, 6, 822, 10.1016/S0735-1097(85)80489-7 Raeder, 1985, Side effects and complications of amiodarone therapy, Am Heart J, 109, 975, 10.1016/0002-8703(85)90238-8 McGovern, 1984, Serious adverse effects of amiodarone, Clin Cardiol, 7, 131, 10.1002/clc.4960070302 Mason, 1985, Toxicity of amiodarone (abstr), Circulation, III Smith, 1986, Long-term tolerance of amiodarone treatment for cardiac arrhythmias, Am J Cardiol, 57, 1288, 10.1016/0002-9149(86)90206-7 Eldar, 1987, Electrophysiologic testing and follow-up of patients with aborted sudden death, J Am Coll Cardiol, 10, 291, 10.1016/S0735-1097(87)80010-4 Helmy, 1988, Use of intravenous amiodarone for emergency treatment of life-threatening ventricular arrhythmias, J Am Coll Cardiol, 12, 1015, 10.1016/0735-1097(88)90470-6 Martin, 1988, Amiodarone pulmonary toxicity: recognition and pathogenesis (Part 1), Chest, 93, 1067, 10.1378/chest.93.5.1067 Kudenchuk, 1980, Prospective evaluation of amiodarone pulmonary toxicity, Chest, 6, 541 Dake, 1985, Gallium-67 lung uptake associated with amiodarone pulmonary toxicity, Am Heart J, 109, 1114, 10.1016/0002-8703(85)90262-5 Colton, 1974, Statistics in Medicine, 237 Cox, 1972, Regression models and life tables (with discussion), J Royal Stat Soc, B34, 187 Podrid, 1981, Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias, Am Heart J, 101, 349, 10.1016/0002-8703(81)90124-1 Gomes, 1984, Programmed electrical stimulation in patients with high-grade ventricular ectopy: electrophysiologic findings and prognosis for survival, Circulation, 70, 43, 10.1161/01.CIR.70.1.43 Swerdlow, 1983, Determinants of survival in patients with ventricular tachyarrhythmias, N Engl J Med, 308, 143, 10.1056/NEJM198306163082402 Kadish, 1986, Amiodarone: correlation of early and late electrophysiologic studies with outcome, Am Heart J, 112, 1134, 10.1016/0002-8703(86)90341-8 Horowitz, 1985, Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease, Am J Cardiol, 55, 367, 10.1016/0002-9149(85)90377-7 Kadish, 1987, Usefulness of electrophysiologic study to determine the clinical tolerance of arrhythmia recurrences during amiodarone therapy, J Am Coll Cardiol, 10, 90, 10.1016/S0735-1097(87)80165-1 Sobol, 1982, Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: a possible complication of a new antiarrhythmic drug, Circulation, 65, 819, 10.1161/01.CIR.65.4.819 Marchlinski, 1982, Amiodarone pulmonary toxicity, Ann Intern Med, 97, 839, 10.7326/0003-4819-97-6-839 Magro, 1985, High incidence of amiodarone pulmonary toxicity: role of diffusion capacity (abstr), Circulation, 72, 111 Guarnieri, 1988, When “sudden cardiac death” is not so sudden: lessons learned from the automatic implantable defibrillator, Am Heart J, 115, 205, 10.1016/0002-8703(88)90546-7 Fogoros, 1987, The automatic implantable cardioverter defibrillator in drug-refractory ventricular tachyarrhythmias, Ann Intern Med, 107, 635, 10.7326/0003-4819-107-5-635